Fanny began her journey with a degree in biomedical engineering, followed by a PhD in translational research. Her doctoral work centered on developing droplet digital PCR methods to identify circulating free DNA biomarkers, advancing personalized cancer patient monitoring. Her passion for technological innovation in translational research led her to the biotech industry, where she initially supported researchers in a field support role. She then transitioned to business development, where she facilitated the adoption of advanced technologies by connecting researchers and democratizing their use across various fields. In her current position, she focuses on promoting the adoption of emerging technologies, including droplet-based single-cell sequencing, aiming to make these state-of-the-art tools more accessible.